AI-generated summary
The authors review clinical studies of photobiomodulation (low-level laser therapy) in oral medicine, outlining its biologic mechanism and summarizing findings for specific applications. They report potential across several conditions and state that research confirms efficacy in oral mucositis, recurrent herpes simplex infection, and burning mouth syndrome. They also note that the literature has a paucity of standardized studies and ambiguity over laser parameters, and that the therapy is not a panacea.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract notes a paucity of standardized studies and ambiguity over laser parameters, which has limited the credibility of the therapy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Laser, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.